{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:45:08Z","timestamp":1775198708195,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jiac.2023.10.007","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T22:03:18Z","timestamp":1697061798000},"page":"213-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparative effectiveness of cefmetazole versus carbapenems and piperacillin\/tazobactam as initial therapy for bacteremic acute cholangitis: A retrospective study"],"prefix":"10.1016","volume":"30","author":[{"given":"Kazuhiro","family":"Aoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4874-0377","authenticated-orcid":false,"given":"Ryo","family":"Inose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Kosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Shikata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6951-5676","authenticated-orcid":false,"given":"Yuichi","family":"Muraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2023.10.007_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/ajg.2011.387","article-title":"The clinical epidemiology and outcomes of bacteremic biliary tract infections caused by antimicrobial-resistant pathogens","volume":"107","author":"Sung","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jiac.2023.10.007_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jhbp.518","article-title":"Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis","volume":"25","author":"Gomi","year":"2018","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jiac.2023.10.007_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2023.10.007_bib4","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.ijid.2012.09.010","article-title":"The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae","volume":"17","author":"Doi","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2023.10.007_bib5","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1128\/AAC.00701-15","article-title":"Multicenter retrospective study of cefmetazole and flomoxef for treatment of extended-spectrum-\u03b2-lactamase-producing Escherichia coli bacteremia","volume":"59","author":"Matsumura","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.10.007_bib6","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s11095-021-03140-7","article-title":"Cefmetazole as an alternative to carbapenems against extended-spectrum beta-lactamase-producing Escherichia coli infections based on in vitro and in vivo pharmacokinetics\/pharmacodynamics experiments","volume":"38","author":"Takemura","year":"2021","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.jiac.2023.10.007_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chron Dis"},{"key":"10.1016\/j.jiac.2023.10.007_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary","volume":"11","author":"Chow","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2023.10.007_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jhbp.509","article-title":"Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis","volume":"25","author":"Miura","year":"2018","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jiac.2023.10.007_bib10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2023.10.007_bib11","series-title":"Performance Standards for antimicrobial susceptibility testing; 32st information supplement. Approved standard M100-Ed32","year":"2022"},{"key":"10.1016\/j.jiac.2023.10.007_bib12","series-title":"Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria","year":"2016"},{"key":"10.1016\/j.jiac.2023.10.007_bib13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2023.10.007_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/cir790","article-title":"\u03b2-Lactam\/\u03b2-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts","volume":"54","author":"Rodr\u00edguez-Ba\u00f1o","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2023.10.007_bib15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/jhbp.452","article-title":"Updated comprehensive epidemiology, microbiology, and outcomes among patients with acute cholangitis","volume":"24","author":"Gomi","year":"2017","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jiac.2023.10.007_bib16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jiac.2018.02.011","article-title":"Antimicrobial susceptibility of common pathogens isolated from postoperative intra-abdominal infections in Japan","volume":"24","author":"Takesue","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2023.10.007_bib17","doi-asserted-by":"crossref","first-page":"635","DOI":"10.14740\/jocmr3928","article-title":"Change in the antimicrobial resistance profile of extended-spectrum \u03b2-lactamase-producing Escherichia coli","volume":"11","author":"Miyazaki","year":"2019","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.jiac.2023.10.007_bib18","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmi.2017.02.027","article-title":"Impact of inadequate initial antimicrobial therapy on mortality in patients with bacteraemic cholangitis: a retrospective cohort study","volume":"23","author":"Tagashira","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2023.10.007_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/jhbp.458","article-title":"Clinical application and verification of the TG13 diagnostic and severity grading criteria for acute cholangitis: an international multicenter observational study","volume":"24","author":"Kiriyama","year":"2017","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jiac.2023.10.007_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/j.1875-9114.1997.tb03067.x","article-title":"Early switch from intravenous to oral antibiotics in hospitalized patients with infections: a 6-month prospective study","volume":"17","author":"Ahkee","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jiac.2023.10.007_bib21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jac\/43.4.601","article-title":"Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital","volume":"43","author":"Sevin\u00e7","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2023.10.007_bib22","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jiac.2021.06.011","article-title":"Ceftriaxone versus tazobactam\/piperacillin and carbapenems in the treatment of aspiration pneumonia: a propensity score matching analysis","volume":"27","author":"Asai","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2023.10.007_bib23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jac\/dkp131","article-title":"Outcomes of early switching from intravenous to oral antibiotics on medical wards","volume":"64","author":"Mertz","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2023.10.007_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12879-018-3184-8","article-title":"Anaerobic coverage as definitive therapy does not affect clinical outcomes in community-onset bacteremic biliary tract infection without anaerobic bacteremia","volume":"18","author":"Wu","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2023.10.007_bib25","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.3748\/wjg.v29.i19.3027","article-title":"Short vs long-course antibiotic therapy in adults with acute cholangitis: a systematic review, meta-analysis, and evidence quality assessment","volume":"29","author":"Kasparian","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jiac.2023.10.007_bib26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1046\/j.1469-0691.2000.00107.x","article-title":"Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs)","volume":"6","author":"Paterson","year":"2000","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2023.10.007_bib27","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/cid\/cix034","article-title":"The use of noncarbapenem \u03b2-lactams for the treatment of extended-spectrum \u03b2-lactamase infections","volume":"64","author":"Tamma","year":"2017","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X23002520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X23002520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:06:47Z","timestamp":1761160007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X23002520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1341321X23002520"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2023.10.007","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness of cefmetazole versus carbapenems and piperacillin\/tazobactam as initial therapy for bacteremic acute cholangitis: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2023.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}